News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Porter Derrell
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/07/2023 |
4
| Porter Derrell (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $5.2, valued at
$130k
|
|
| 05/26/2023 |
4
| Porter Derrell (Director) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 24,000 options to buy
@ $1, valued at
$24k
|
|
| 01/04/2023 |
4
| Porter Derrell (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options to buy
@ $5.46, valued at
$273k
|
|
| 01/04/2023 |
3
| Porter Derrell (Director) has filed a Form 3 on Acumen Pharmaceuticals, Inc. |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/27/2019 |
4
| Porter Derrell (SVP, Head of Global Commercial) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 02/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/08/2018 |
4
| Porter Derrell (SVP, Head of Global Commercial) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 1,544 shares
@ $40.15, valued at
$62k
|
|
| 02/08/2018 |
4
| Porter Derrell (SVP, Head of Global Commercial) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 12,500 shares
@ $0
Granted 25,000 options to buy
@ $35.8, valued at
$895k
|
|
| 05/11/2017 |
4
| Porter Derrell (SVP, Head of Global Commercial) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 130,000 options to buy
@ $14.3, valued at
$1.9M
|
|
| 05/11/2017 |
3
| Porter Derrell (SVP, Head of Global Commercial) has filed a Form 3 on Atara Biotherapeutics, Inc. |
|
|